Brief: Eurobio Scientific FY Consolidated EBITDA Down At EUR 40.5 Million

Eurobio Scientific SA

05/04/2023 16:55

April 5 (Reuters) - Eurobio Scientific SA  ALERS.PA :
    * 2022 ANNUAL RESULTS
    * ROBUST FINANCIAL POSITION WITH EUR 22 MLN OF NET DEBT, OF
WHICH
EUR 86 MLN OF CASH
    * FY EXCELLENT CASH GENERATION CAPACITY AT EUR 43 MLN
    * CORE BUSINESS REVENUES UP 15% TO EUR 93.5 MLN (+53% SINCE
2019)
    * FY CONSOLIDATED EBITDA EUR 40.5 MILLION VERSUS EUR 77.9
MILLION
YEAR AGO
    * GROSS MARGIN REACHED 46.7% OF SALES COMPARED TO 55.5% IN
2021
    * SHOWED A CASH POSITION OF EUR 86 MILLION AT DECEMBER 31,
2022,
FOR A FINANCIAL DEBT OF EUR 108 MILLION, I.E. A NET FINANCIAL
DEBT OF EUR 22 MILLION, LEAVING ITS INVESTMENT CAPACITY INTACT
FOR COMING YEARS
    * FY NET RESULT EUR 24.9 MILLION VERSUS EUR 60.5 MILLION
YEAR AGO

Source text for Eikon:  ID:nGNE2cvlT2 
Further company coverage:  ALERS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))